Diabetic cardiomyopathy: ongoing controversies in 2012

Area of Science:

• Cardiology
• Endocrinology
• Pathology

Background:

• Diabetic cardiomyopathy is a cardiac complication of diabetes mellitus.
• It is characterized by left ventricular diastolic dysfunction unexplained by other cardiac conditions.
• Previous prevalence estimates were high, but recent studies indicate a lower incidence.

Purpose of the Study:

• To clarify the definition and prevalence of diabetic cardiomyopathy.
• To outline the pathological mechanisms involved.
• To discuss current and potential therapeutic strategies.

Main Methods:

• Review of existing literature on diabetic cardiomyopathy.
• Analysis of diagnostic criteria and patient selection in prevalence studies.
• Examination of pathophysiological pathways and clinical manifestations.

Main Results:

• Diabetic cardiomyopathy is defined by diastolic dysfunction in diabetic patients without other cardiac causes.
• More stringent diagnostic criteria reveal a significantly lower prevalence than previously reported.
• Pathological features include myocardial damage, fibrosis, hypertrophy, and vascular changes.

Conclusions:

• Diabetic cardiomyopathy involves hyperglycemia-induced oxidative stress, inflammation, and insulin resistance contributing to cardiac dysfunction.
• Current treatments lack specificity but include improving glycemic control, lifestyle modifications, and standard cardiovascular medications.
• Further research is needed for targeted therapies addressing the underlying pathophysiology.